看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | -0.1x - -0.1x | -0.1x |
| Historical Pb Multiple | -0.1x - 5.3x | 0.6x |
| Fair Value | $0.025 - $0.027 | $0.026 |
| Upside | -52.5% - -47.5% | -50.0% |
| Benchmarks | - | Full Ticker |
| Boston Scientific Corporation | - | NYSE:BSX |
| Abbott Laboratories | - | NYSE:ABT |
| Medtronic plc | - | NYSE:MDT |
| Merit Medical Systems, Inc. | - | NasdaqGS:MMSI |
| Vycor Medical, Inc. | - | OTCPK:VYCO |
| Acutus Medical, Inc. | - | OTCPK:AFIB |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| BSX | ABT | MDT | MMSI | VYCO | AFIB | |||
| NYSE:BSX | NYSE:ABT | NYSE:MDT | NasdaqGS:MMSI | OTCPK:VYCO | OTCPK:AFIB | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | -17.0% | 29.5% | -4.5% | 85.7% | NM- | NM- | ||
| 3Y CAGR | 23.4% | 23.8% | 0.6% | 35.4% | NM- | NM- | ||
| Latest Twelve Months | 18.0% | 134.2% | 1.4% | 27.5% | -24.5% | 61.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 12.3% | 15.3% | 13.5% | 4.6% | -36.0% | -1081.2% | ||
| Prior Fiscal Year | 11.0% | 14.2% | 12.0% | 7.5% | -59.2% | -166.4% | ||
| Latest Fiscal Year | 11.1% | 31.8% | 11.4% | 8.9% | -26.5% | -22.5% | ||
| Latest Twelve Months | 11.1% | 31.8% | 12.8% | 8.9% | -35.7% | -22.5% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 9.7% | 17.4% | 8.1% | 4.8% | NA | -61.4% | ||
| Prior Fiscal Year | 8.5% | 15.1% | 7.2% | 8.0% | NM | -31.8% | ||
| Latest Twelve Months | 9.0% | 31.0% | 8.4% | 9.3% | NM | NM | ||
| Next Fiscal Year | 17.8% | 18.2% | 14.1% | 15.1% | -78.9% | 141.6% | ||
| Two Fiscal Years Forward | 17.0% | 18.4% | 15.4% | 14.7% | 27.9% | 36.4% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 9.0x | 5.2x | 3.4x | 4.5x | 1.5x | 0.1x | ||
| Price / LTM EPS | 81.2x | 16.4x | 26.6x | 50.9x | -4.2x | -0.3x | ||
| Price / Book | 6.9x | 4.6x | 2.3x | 4.4x | -0.6x | -0.1x | ||
| Price / Fwd Book | 5.9x | 4.2x | 2.3x | 3.8x | -1.5x | 0.0x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | -0.6x | 4.4x | 6.9x | |||||
| Historical P/B Ratio | -0.1x | 0.6x | 5.3x | |||||
| Selected P/B Multiple | -0.1x | -0.1x | -0.1x | |||||
| (x) Book Value | (12) | (12) | (12) | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | BSX | ABT | MDT | MMSI | VYCO | AFIB | |
| Value of Common Equity | 152,463 | 217,831 | 113,621 | 6,162 | 2 | 2 | |
| (/) Shares Outstanding | 1,479.1 | 1,734.3 | 1,282.5 | 58.8 | 33.4 | 29.9 | |
| Implied Stock Price | 103.08 | 125.60 | 88.59 | 104.74 | 0.06 | 0.05 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 103.08 | 125.60 | 88.59 | 104.74 | 0.06 | 0.05 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |